Gastroenterology by Cassani, Barbara et al.
Gut-tropic T Cells that Express Integrin α4β7 and CCR9 are
Required for Induction of Oral Immune Tolerance in Mice
Barbara Cassani1,*, Eduardo J. Villablanca1,*, Francisco J. Quintana2, Paul E. Love3, Adam
Lacy-Hulbert4, William S. Blaner5, Tim Sparwasser6, Scott B. Snapper7, Howard L. Weiner2,
and J. Rodrigo Mora1,**
1Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA
02114
2Center for Neurologic Diseases, Brigham and Women's Hospital, Harvard Medical School,
Boston, MA 02115
3Eunice Kennedy Schriver, National Institute of Child Health and Human Development, National
Institutes of Health, Bethesda, MD, 20892
4Department of Pediatrics, Massachusetts General Hospital, Harvard Medical School, Boston,
MA 02114
5Department of Medicine, Columbia University, New York, NY 10032
6Institute of Infection Immunology, Centre for Experimental and Clinical Infection Research,
Twincore, 30625 Hannover, Germany
7Gastrointestinal Unit, Children's Hospital & Brigham and Women's Hospital, Harvard Medical
School, Boston, MA 02115
Abstract
BACKGROUND & AIMS—Induction of oral immunological tolerance (OT) blocks
proinflammatory responses to orally administered antigens; this approach might be used to treat
autoimmune conditions. We investigated whether gut-tropic T cells that express the integrin α4β7
and the chemokine receptor CCR9 are required for OT.
METHODS—Skin delayed-type hypersensitivity and experimental autoimmune
encephalomyelitis were used to monitor OT in mice. To assess the role of receptors that mediate
localization of lymphocytes to the gut (gut-homing receptors) in induction of OT, we studied
CCR9−/− and β7−/− mice, and also blocked the α4β7 ligand MAdCAM-1 in wild-type mice. We
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used DEREG and Scurfy mice to assess the role of Foxp3+ regulatory T (TREG) cells, and IL-10−/
− and IL-10Rβ−/− mice to examine the role of IL-10, in induction of OT.
RESULTS—OT could not be induced in CCR9−/− or β7−/− mice, or when MAdCAM-1 was
blocked in wild-type mice, indicating that gut-homing receptors are required for oral tolerization.
Consistent with the role of all-trans retinoic acid in inducing gut homing T cells, OT could not be
induced in mice depleted of vitamin A. OT was rescued in CCR9−/− mice following adoptive
transfer of wild-type T cells, but not CCR9−/− or β7−/− T cells. Gut-homing T cells are therefore
necessary and sufficient to induce OT. Wild-type TREG cells and IL-10 were required to restore
OT to CCR9−/− mice, indicating that homing and functional differentiation of IL-10-producing
TREG cells in the gut is required for OT. Conversely, transfer of CCR9−/− or β7−/− T cells to
wild-type mice partially inhibited OT.
CONCLUSIONS—Expression of CCR9 and α4β7 on T cells and their subsequent localization to
the gut is required for induction of oral immunological tolerance in mice. Therapies designed to
block gut-homing receptors might, under some conditions, interfere with normal tolerogenic
mechanisms in the intestinal mucosa.
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Two general mechanisms have been proposed to induce OT. Feeding high doses of antigen
typically results in T cell clonal deletion and/or anergy1, while low doses/repeating regimes
of oral antigen administration lead to active immunosuppression by inducing regulatory T
cells2, 3. Although orally administered antigens can be presented to T cells by dendritic cells
(DC) in Peyer's patches (PP) and mesenteric lymph nodes (MLN), it has been shown that
OT requires MLN4, 5 but not PP4. In this setting, orally administered antigens are captured
by DC in the intestinal lamina propria (LP) and transported to MLN via the lymph. DC from
MLN, PP and small intestine lamina propria (gut-associated DC) induce high expression of
gut-homing receptors integrin α4β7 and chemokine receptor CCR9 on lymphocytes upon
activation6. The capacity of gut-associated DC to imprint gut-tropism on lymphocytes is
explained by their selective capacity to metabolize vitamin A into RA7, and RA is necessary
and sufficient to induce gut-tropic α4β7+CCR9+ T and B cells in mice and humans6, 7.
Moreover, RA, in the presence of TGF-β, potentiates the induction of Foxp3+ regulatory T
cells (TREG)8, 9, which are required for the establishment of OT2. We hypothesized that RA-
dependent induction of gut-homing T cells is critically required for OT by promoting the
differentiation of tolerogenic TREG in the gut lamina propria and by re-directing potentially
pro-inflammatory T cells to the gut mucosa.
Methods
Mice
Wt, β7−/−, Scurfy, and IL-10−/− mice were purchased from Jackson Laboratories (Bar
Harbor, ME). CCR9−/− and LRAT−/− mice have been described10, 11. DEREG mice12 were
provided by Dr. Thorsten Mempel (MGH, Boston). Experiments using IL-10Rβ−/− mice
were done in collaboration with Dr. Scott Snapper (Children's Hospital, Boston). All mouse
strains were used between 8–13 weeks of age. Mice were maintained in SPF/VAF animal
facilities at MGH and used in accordance with the guidelines from the Subcommittee on
Research Animal Care at MGH and HMS.
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Mice were fed daily either 2.5 mg OVA or 0.25 mg MOG peptide (MOG35–55) via oral
gavage for 5 days, as described3, 13.
DTH
Mice were injected s.c. with 200 μl OVA/CFA emulsion (250 μg OVA plus 100 μl CFA) in
the tail base. Seven days later the mice were challenged with 50 μl of aggregated OVA (10
μg/ml) injected into the left footpad. The right footpad (control) received 50 μl of PBS. The
thickness of both hind footpads was measured 24 hours later with a caliper. Specific DTH
was calculated as the difference between the left and the right footpad.
Statistical analysis
Data are presented as mean ± SEM and were analyzed using GraphPad Prism Software 5.0c
(La Jolla, CA). Significance was determined using unpaired Student's t test or one-way
ANOVA with Bonferroni's post-hoc tests, as appropriate.
Results
CCR9 is required for OT induction
To test the role of gut-homing lymphocytes in OT we used CCR9−/− mice, whose T cells are
significantly impaired in their capacity to migrate to the small bowel6, we used the classical
ovalbumin (OVA) skin DTH model as OT readout3, 13. If gut-homing is required for the
establishment of OT we predicted that mice lacking CCR9 would develop DTH despite of
being pre-treated orally with OVA. DTH was induced equally efficiently in wt and CCR9−/−
mice that received oral PBS, indicating that CCR9 is not required for T cell recall responses
or DTH induction. However, oral OVA administration prevented DTH responses only in wt
mice, whereas CCR9−/− mice developed DTH regardless of whether they were pre-treated
orally with OVA (Fig. 1A). Moreover, oral OVA did not decrease ex vivo OVA-specific cell
proliferation in splenocytes from CCR9−/− mice, while it efficiently suppressed systemic
recall responses in wt mice (Fig. 1B). As expected, polyclonal T cell activation induced
similar levels of cell proliferation and IFN-γ production in orally tolerized wt and CCR9−/−
mice (Fig. S1). IL-10 is critical for OT14, 15 and IL-4 seems to play a role in OT under some
conditions15. Accordingly, systemic IL-10- and IL-4-producing cells were readily induced in
wt mice, but not in CCR9−/− mice supplemented with oral OVA (Fig. 1C and Table S1).
Reciprocally, the production of IL-2 and IFN-γ was reduced in splenocytes from wt mice
upon oral OVA administration, while it was not affected in CCR9−/− mice.
Similar to spleen, CD4+ T cells isolated from draining popliteal PLN of orally tolerized wt
but not CCR9−/− mice displayed lower OVA-specific proliferative responses and IFN-γ
production than CD4+ T cells from mice given oral PBS (Fig. S2A, B), an effect that was
mirrored by reduced cellularity in PLN of wt as compared to CCR9−/− mice (Fig. S2C).
Moreover, increased IL-10 production was consistently observed at the protein and mRNA
levels in OVA-stimulated CD4+ T cells from PLN of orally tolerized wt but not CCR9−/−
mice (Fig. S2D, E). Immunomodulation in OT also involves TGF-β-producing cells16.
Correspondingly, enhanced levels of Tgfb1 mRNA were detected in CD4+ T cells from PLN
of orally tolerized wt but not CCR9−/− mice (Fig. S2F).
To extend our results to another OT experimental system we used the EAE model, in which
OT can be generated by orally supplementing mice with a peptide derived from myelin
oligodendrocyte glycoprotein (MOG35–55)1, 17. EAE developed similarly in wt and CCR9−/−
mice supplemented orally with PBS (Fig. 1D), indicating that CCR9 is not required for EAE
pathogenesis. However, orally administered MOG35–55 prevented EAE only in wt but not in
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CCR9−/− mice. Accordingly, cell proliferation upon ex vivo re-stimulation with MOG35–55
was significantly reduced in splenocytes from MOG-tolerized wt mice, but not in cells from
CCR9−/− mice (Fig. 1E). Th17 and Th1 cells are involved in EAE and DTH pathogenesis
and OT induction abrogates the generation of these pro-inflammatory T cells18, 19.
Consistently, MOG-tolerized wt mice showed lower frequencies of IL-17- and IFN-γ-
producing cells as compared to non-tolerized controls. However, CCR9−/− mice did not
show a decrease in the proportions of Th17 or Th1 cells upon oral MOG35–55 administration
(Fig. S3). In summary, our results using two independent experimental systems indicate that
CCR9 is critical for OT generation.
Blocking MAdCAM-1 blocks migration of antigen-specific T cells to the gut and abrogates
OT in wt mice
As a complementary approach we assessed the role of α4β7-MAdCAM-1, the other gut-
homing receptor pair6, in OT. Treatment of wt mice with a blocking mAb against
MAdCAM-1 (clone MECA-367) increased the frequencies of systemic α4β7+ effector/
memory CD4 T cells, an effect that was significantly more pronounced in mice that were
orally supplemented with OVA (Fig. 2A, B), suggesting that oral OVA administration
generated OVA-specific gut-homing CD4 T cells and that blocking α4β7-MAdCAM-1
interaction prevented the migration of these cells to the gut, hence increasing their peripheral
frequency. Given the low frequencies of endogenously generated OVA-specific CD4 T cells
in OVA-tolerized mice, we could not reliably detect these cells in the small intestine lamina
propia (LP). Nevertheless, adoptively transferred OT-II T cells (Vβ5.1+) were readily
detected in the LP upon oral OVA supplementation (days 3 and 6) and they were markedly
decreased by anti-MAdCAM-1 mAb (Fig. S4), indicating that OVA-specific T cells traffic
to the small bowel LP upon activation in the MLN and that their homing to the LP is
efficiently blocked by anti-MAdCAM-1 treatment.
Importantly, similar to CCR9−/− mice, anti-MAdCAM-1 mAb prevented OT in wt mice, as
evidenced by increased skin DTH, higher in vitro OVA-specific proliferation, enhanced ex
vivo IL-2 and IFN-γ production, and lack of induction of systemic IL-10-producing cells as
compared with mice treated with control rIgG (Fig. 2C–E). Thus, our data indicate that both
gut-homing receptor pairs, CCR9-CCL25 and α4β7-MAdCAM-1, are required for OT.
OT is abolished in vitamin A depleted (VAD) mice
Since RA is required for imprinting gut-tropic α4β7+ CCR9+ lymphocytes, we predicted that
vitamin A-depleted (VAD) mice should be impaired in OT induction. For vitamin A
depletion we used mice deficient in lecithin:retinol acyltransferase (LRAT−/−), which cannot
store vitamin A in the liver and therefore can readily become VAD after only 2–3 weeks on
a VAD diet, hence avoiding potential side effects of long-term vitamin A depletion10. DTH
was similarly induced in mice on a control or VAD diet, indicating that RA is not required
for recall T cell responses during DTH induction. However, OT was abrogated in VAD
mice, as shown by increased skin DTH, higher in vitro OVA-specific proliferation and IL-2
production, and lack of systemic IL-10-producing cells when compared to mice on a control
vitamin A-sufficient diet (Fig. 3A–C and Table S2). As expected, ex vivo polyclonal T cell
activation induced similar levels of cell proliferation and IFN-γ production in control and
VAD mice (Fig. S5A). Of note, although RA has been shown to promote TREG
differentiation8, 9, VAD mice exhibited only a mild decrease in TREG frequencies in MLN
(Fig. S5B), which is in line with recent data indicating that VAD mice do not show a
decrease in total TREG20.
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Adoptive transfer of wt naïve T cells or gut-tropic T cells rescues OT in CCR9−/− and VAD
mice, respectively
Next, we assessed which cell types need to express gut-homing receptors during OT
induction. In addition to T cells, plasmacytoid DC (pDC) also play an important role in
OT2, 13. Therefore, we explored whether wt T cells or pDC were sufficient to rescue OT in
CCR9−/− mice. For this purpose, we adoptively transferred T cells or pDCs from non-
tolerized wt or CCR9−/− donors into CCR9−/− recipient mice prior OT induction.
Remarkably, adoptive transfer of wt T cells (CD45.1+) (Fig. S6A) was sufficient to fully
restore OT in CCR9−/− mice, as indicated by reduced DTH responses, decreased ex vivo
OVA-specific T cell proliferation and increased numbers of IL-10 producing cells upon oral
OVA administration as compared to CCR9−/− mice adoptively transferred with a similar
number of CCR9−/− T cells (Fig. 4A–C and Fig. S6B). Of note, transfer of β7−/− CCR9+/+ T
cells did not rescue OT in CCR9−/− mice (Fig. 4D and Fig. S6C), indicating that T cells
need both CCR9 and α4β7 in order to rescue OT in CCR9−/− mice. On the other hand,
adoptive transfer of wt pDC from BM was not sufficient to rescue OT in CCR9−/− mice
(Fig. S6D, E).
We then asked whether adoptive transfer of T cells could also rescue OT in VAD mice.
However, gut-homing induction is abrogated in mice lacking RA7, 21. Therefore, to bypass
the lack of gut-homing imprinting in VAD mice, we generated gut-tropic T cells ex vivo by
activating naïve CD4 T cells from Thy1.1+ OT-II mice in the presence of RA7. Notably, ex
vivo-generated gut-tropic OT-II CD4 T cells were sufficient to rescue OT induction in VAD
mice (Fig. S7), suggesting that the most critical role of RA in OT is the induction of gut-
tropic T cells, rather than other potential immune effects of RA, such as promoting TREG
and IgA-ASC differentiation8, 9.
Gut-homing receptors on TREG are required to rescue OT in CCR9−/− mice
We assessed the role of TREG in our experimental system. For depleting TREG we used
DEREG mice, which express diphtheria toxin (DT) receptor (DTR)-GFP under the control
of the Foxp3 promoter. In line with previous work2, 3, TREG depletion in DT-treated
DEREG mice abrogated OT (Fig. S8A–C). As expected, DT treatment did not interfere with
DTH or OT generation in wt (non-DEREG) mice (Fig. S8B–C). Interestingly, despite that
endogenous CCR9−/− TREG are found in CCR9−/− recipient mice (Fig. S8D), they were not
sufficient for allowing OT induction in the absence of adoptively transferred wt T cells (Fig.
1), suggesting that TREG need to express CCR9 in order to allow for OT induction.
Consistent with this possibility, specific depletion of CCR9+/+ TREG derived from
adoptively transferred DEREG CD4 T cells abolished OT rescue in CCR9−/− mice (Fig. 4E,
F and Fig. S8E). Analogous to CCR9−/− mice, OT was also abolished in β7−/− mice.
Whereas wt CD4 T cells partially recued OT in β7−/− mice, CD4 T cells from Scurfy mice,
which lack functional Foxp322, did not rescue OT in these mice (Fig. S9), confirming the
key role of gut-tropic TREG in OT.
Previous reports suggested that naturally occurring thymus-derived TREG (nTREG) are not
required for OT16, whereas adaptive/induced TREG (iTREG) play a critical role in OT
generation23, 24. In line with these data, CD4 T cells from DEREG mice depleted of nTREG
rescued OT in CCR9−/− mice, whereas additional TREG depletion during oral OVA
supplementation prevented OT rescue in CCR9−/− mice (Fig. S10). Thus, our data suggest
that newly generated OVA-specific iTREG need to express CCR9 in order to generate OT.
Gut-homing and IL-10 signaling are required for the generation of tolerogenic IL-10+ TREG
TREG2, 23, 25 and IL-10 are critical for OT14, 15. Our results indicate that upon OT induction
the production of IL-10 and TGF-β1 is mostly confined to Foxp3+CD4+ TREG (Fig. S11A).
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Moreover, in agreement with a critical role of gut-homing during OT, anti-MAdCAM-1
treatment abrogated IL-10 production by TREG (Fig. S11B). In addition, adoptive transfer of
naïve CD4 T cells from IL-10−/− mice failed to rescue OT and did not induce OVA-specific
IL-10-producing cells in CCR9−/− mice upon oral OVA administration (Fig. 5A). Therefore,
our data suggest that gut-tropic wt (IL-10+/+) CD4 T cells are required for the generation of
IL-10+ TREG in OT.
It has been proposed that IL-10 signaling is required on TREG to maintain their Foxp3
expression and suppressive function26, 27. Interestingly, similar to IL-10−/− T cells, adoptive
transfer of CD4 T cells from IL-10Rβ−/− mice did not induce OVA-specific IL-10-
producing cells in CCR9−/− mice upon oral OVA administration (Fig. 5B), suggesting that
gut-homing CD4 T cells need to be exposed to IL-10 signals in the gut to become fully
tolerogenic IL-10-producing cells in OT.
Transfer of CCR9−/− or β7−/− T cells impairs OT in wt mice
Since oral antigen directs antigen-specific effector T cells to the gut mucosa by inducing
α4β7 and CCR96, we reasoned that, analogous to clonal deletion/anergy17, targeting T cells
to the gut could be an alternative mechanism for excluding effector T cells from peripheral
immune responses. Thus, we predicted that T cells deficient in gut-homing capacity might
interfere with OT generation in wt mice. Consistent with this possibility, adoptive transfer of
CCR9−/− or β7−/− T cells partially abrogated OT induction in wt mice, as determined by
enhanced DTH responses and an increased OVA-specific T cell proliferation as compared
with control wt mice (Fig. 6).
Discussion
The prevailing view indicates that OT relies on the induction of antigen-specific TREG in the
MLN, which then reach the blood and suppress pro-inflammatory responses in different
tissues2, 3, 5, 23, 25, 28. However, although priming of naïve T cell in MLN is required for
OT4, 5, our data indicate that T cell activation in MLN is not sufficient for OT induction.
This is despite the fact that TREG are readily generated in MLN upon oral immunization and
that MLN-DC are sufficient to induce TREG ex vivo9, 29, 30. We propose that TREG require a
second activation step in the small intestine LP to complete their differentiation into fully
tolerogenic IL-10-producing TREG, which can then suppress pro-inflammatory responses
(Fig. 7). While the first step in MLN involves naïve T cells and therefore does not require
gut-homing receptors, we propose that the second step in the small intestine LP depends on
the induction of retinoic acid (RA)-dependent6 gut-homing receptors α4β7 and CCR9 on
differentiating TREG. Of note, homing to the gut is also required for further TREG expansion
in the lamina propria24, 31 and our results indicate that gut-homing induction might also
target effector T cells to the intestinal mucosa, making them unavailable to participate in
pro-inflammatory responses at peripheral sites.
IL-1014, 15, 31 and TGF-β16 are required for OT induction in different models. Given that the
induction of systemic antigen-specific IL-10- and TGF-β-producing cells was markedly
decreased in mice with impaired gut-homing, our data suggest that T cells need to migrate to
the gut to become IL-10- and/or TGF-βproducing TREG. In fact, while intestinal TREG
secrete IL-10, spleen TREG do not produce this critical tolerogenic cytokine32, which is
consistent with our hypothesis of functional TREG specialization in the gut lamina propria in
the setting of OT. Moreover, our results suggest that IL-10 signals on gut-tropic TREG are
critical for promoting the differentiation of fully tolerogenic IL-10+ TREG during OT.
Among the possible sources for IL-10 in the LP are CX3CR1+ macrophages24, 26 and
CD11b+ DC33.
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Of note, OT induction in an asthma model was recently correlated with the presence of a
subset of CCR9+ IL-10-producing TREG in the airways, leading to the speculation that
CCR9 might be required for TREG homing to the airway mucosa upon OT induction31.
However, since CCR9 has not been shown to play a role in lung homing, we propose that
CCR9 expression on TREG in the asthma OT setting might reflect TREG priming in MLN by
orally administered antigens and their subsequent differentiation in the small bowel LP into
IL-10+ TREG, which then migrate to the lung mucosa to suppress airway inflammation.
Interestingly, a subset of IL-10-producing cells has been specifically found among
circulating memory CCR9+ CD4 T cells in healthy human volunteers, whereas memory
CCR9Neg CD4 T cells did not produce IL-1034, suggesting that human T cells might also
need to express CCR9 in order to acquire tolerogenic IL-10-producing potential.
Other functions have been proposed for CCR9 in addition to gut-homing, such as effects on
T cell apoptosis35 and on T cell-epithelial cells interaction36. Nevertheless, since our data
showed that the other gut-homing receptor pair α4β7-MAdCAM-1 is also critical for OT
induction, we favour the hypothesis that bona fide α4β7- and CCR9-expressing gut-tropic T
cells are required for OT. Moreover, given that the CCR9-CCL25 receptor pair plays a role
only in small bowel homing6, especially in the upper segments37, we propose that T cell
homing to the upper portions of the small bowel might be especially important for
generating IL-10+ TREG and OT. In agreement with this possibility, previous studies showed
that antigen administration in the upper intestinal segments was more effective than
inoculation in the ileum or colon for inducing OT38.
Even though RA promotes TREG induction ex vivo9, 29, 30, its in vivo role in TREG
differentiation remains unclear. In fact, VAD mice did not show a decrease in TREG in MLN
or the lamina propria20. Moreover, OT could be rescued in VAD mice by adoptively
transferring exogenously generated gut-tropic antigen-specific CD4 T cells, suggesting that
additional non gut-homing related roles for RA might not be essential during OT. Therefore,
our data showing impaired OT in VAD are more likely explained by decreased gut-homing
imprinting rather than by a direct effect on TREG generation, which is in line with our data in
CCR9−/− mice or in wt mice after blocking MAdCAM-1.
Although adoptive transfer of spleen TREG from orally tolerized mice is sufficient to confer
tolerance to naïve mice39, plasmacytoid DC (pDC) have also been proposed to play a key
role in OT2, 13 and adoptive transfer of pDC from orally tolerized mice was also sufficient to
tolerize naïve mice in a DTH model13. In fact, a subset of immature pDC also expresses
CCR940 and CCR9 plays a role in pDC homing to the gut41. However, in contrast to wt T
cells, adoptive transfer of wt bone marrow CCR9+ pDC was not sufficient to rescue OT in
CCR9−/− mice. Nonetheless, it is formally possible that intravenously administered pDC did
not home in sufficient numbers and/or to the proper tissue compartments.
In addition to active immunosuppression by TREG and clonal deletion/anergy17, our data
suggest that induction of α4β7CCR9+ gut-tropic T cells is an alternative mechanism for OT
by excluding effector, pro-inflammatory T cells from inducing potentially pathogenic
immune responses at the peripheral sites. In fact, intestinal effector/memory T cells exhibit a
very slow turnover and have a long dwell-time in the gut42, which might act like
sequestering T cells. Conversely, interfering with gut-homing imprinting would allow
effector T cells to remain in the periphery, potentially interfering with OT induction. Our
experiments transferring T cells genetically deficient in gut-homing receptors emulate this
scenario, as those cells are not targeted to the gut mucosa even when they are primed in gut-
associated lymphoid compartments. Our findings might offer a partial explanation for the
difficulty to mount tolerogenic responses during ongoing inflammatory responses as
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compared to prophylactic tolerogenic treatments43. In this setting, peripherally primed T
cells, induced in the context of extra-intestinal inflammation, would not acquire gut-homing
receptors and therefore would not be efficiently targeted to and eventually retained in the gut
mucosa.
In summary, our findings highlight a novel and unexpected link between gut-homing
imprinting and mucosal immunological tolerance. In addition to establishing a novel role for
gut-homing imprinting, our data suggest a need for caution when using immunotherapies
aimed at blocking gut-homing receptors during chronic intestinal inflammation44, because
of their potential to interfere with normal homeostatic regulatory mechanisms in the
intestinal mucosa.
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Figure 1. CCR9 is required for OT induction
(A–C) Wild type (wt) and CCR9−/− mice were supplemented daily with oral PBS or 2.5 mg
OVA for 5 days, and then they were immunized s.c. with OVA plus CFA. After 7 days the
mice were challenged with OVA in the left footpad and PBS in the right footpad. (A) DTH
responses were measured after 24 hours (n=7–9 mice/group). (B, C) Total splenocytes were
stimulated with 1 mg/ml OVA. (B) Cell proliferation was assessed after 72 hours. (C)
Cytokines were measured in the culture supernatant after 24–48 hours. (D, E) Wt and
CCR9−/− mice were supplemented daily with oral PBS or 0.25 mg MOG35–55 for 5 days,
then immunized s.c. with MOG35–55 plus CFA. (D) EAE induction and progression was
scored from days 11 to 25 (n=8–10 mice/group). (E) At day 16, the mice were sacrificed and
total splenocytes were stimulated ex vivo with 20 μg/ml MOG35–55. T cell proliferation was
measured after 72 hours (n=4 mice/group). Mean ± SEM, *p<0.05, **p<0.01, ***p<0.001,
n.s.: not significant.
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Figure 2. Blocking MAdCAM-1 abrogates OT in wt mice
Wt mice were treated i.p. with anti-MAdCAM-1 or control rIgG. OT and DTH were induced
as described in Fig. 1. (A) Flow cytometry analysis of one representative mouse/group. (B)
Frequencies of α4β7- and CCR9-expressing cells in the spleen. Cells were gated on
CD44HiCD62LLow effector/memory CD4+ T cells (C) DTH responses were measured after
24 hours (n=2–3 mice/group). (D, E) Total splenocytes were stimulated with the indicated
OVA concentrations. (D) Proliferation was measured after 72 hours (n=2–3 mice/group).
(E) Cytokines were measured in the culture supernatant after 24–48 hours. Mean ± SEM,
*P<0.05, *P<0.01,***P<0.001, n.s.: not significant.
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Figure 3. OT is abolished in vitamin A depleted (VAD) mice
Mice were maintained on a control or VAD diet. OT and DTH were induced as described in
Fig. 1. (A) DTH responses (footpad swelling) were measured after 24 hours, and were
expressed as the difference between the left and right footpad (L-R) (n=4 mice/group). (B,
C) Total splenocytes were stimulated with 1 mg/ml OVA. (B) T cell proliferation was
measured after 72 hours. (C) Cytokines were measured in the culture supernatant after 24–
48 hours. Mean ± SEM, *p<0.05, **p<0.01, ***p<0.001, n.s.: not significant.
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Figure 4. Adoptive transfer of wt T cells rescues OT in CCR9−/− mice
T cells from nontolerized wt or CCR9−/− mice were adoptively transferred into CCR9−/−
recipients. OT and DTH were induced as described in Fig. 1. CCR9−/− mice receiving CD4+
T cells from DEREG mice were treated with DT every day. (A, E) DTH responses were
measured after 24 hours (n=2–5 mice/group). (B–D, F) Total splenocytes were stimulated
with the indicated OVA concentrations. (B, D, F) Proliferation was assessed after 72 hours
(n=4–5 mice/group). (C) IL-10 was measured in the culture supernatant after 48–60 hours.
Mean ± SEM, *p<0.05, ***p<0.001
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Figure 5. IL-10 signals in gut-tropic TREG are critical for OT
T cells from IL-10−/− or IL-10Rβ−/− mice were adoptively transferred into CCR9−/− mice.
OT and DTH were induced as described in Fig. 1. (A) Total splenocytes were stimulated
with the indicated OVA concentrations and cell proliferation was measured after 72 h. (B,
C) Cytokines were measured in the culture supernatant after 48–60 hours. n=2 mice/group,
Mean ± range
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Figure 6. Transfer of CCR9−/− or β7−/− T cells impairs OT in wt mice
T cells from CCR9−/− or β7−/− mice were adoptively transferred into wt mice. OT and DTH
were induced as described in Fig. 1. (A) DTH responses were measured after 24h (n= 2
mice/group). Groups were compared versus wild type mice receiving oral PBS. (B) Total
splenocytes were stimulated with the indicated OVA concentrations and cell proliferation
was measured after 72h (n= 2 mice/group). Mean ± SEM, *p<0.05 (ANOVA)
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Figure 7. Gut-homing-dependent model for OT
(A) The prevailing view indicates that OT relies on the induction of antigen-specific Foxp3+
regulatory T cells (TREG) in the mesenteric lymph nodes (MLN), which then reach the blood
and suppress pro-inflammatory responses in different tissues. (B) In our new model we
propose that TREG require a second activation step in the intestinal lamina propria (LP) to
complete their differentiation into fully tolerogenic IL-10-producing TREG, which can then
suppress pro-inflammatory responses. While the first step in MLN involves naïve T cells
and therefore does not require gut-homing receptors, the second step in the gut LP depends
on the induction of retinoic acid (RA)-dependent gut-homing receptors α4β7 and CCR9 on
activated TREG and their respective ligands MAdCAM-1 and CCL25 on LP endothelial
cells. In the LP TREG are re-stimulated and proliferate in response to oral antigen and they
are also exposed to IL-10, which is required to confer TREG with IL-10-producing capacity,
a critical property for OT generation. After that, IL-10+ TREG return to the blood and exert
their tolerogenic activity in different organs.
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